Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner announcing NIH website changes and explaining the agency’s terminology transition was removed; the page continues to show a 403 error.
    Difference
    1%
    Check dated 2026-11-07T11:30:53.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T11:08:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence” across some content.
    Difference
    1%
    Check dated 2026-10-24T11:13:36.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T12:39:11.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T13:03:19.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content; the additions include the 403 text and header, while the deletions remove the previously visible study metadata and links.
    Difference
    17%
    Check dated 2026-09-19T19:15:16.000Z thumbnail image

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.